Phase 4 ERP Clinical Trials
17 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–17 of 17 trials
Recruiting
Phase 4
A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland
Herpes Zoster
GlaxoSmithKline33,609 enrolled8 locationsNCT07502560
Recruiting
Phase 4
A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the Prostate
Benign Prostatic HyperplasiaNocturia Associated With Nocturnal Polyuria
The Fourth Affiliated Hospital of Zhejiang University School of Medicine136 enrolled1 locationNCT07357324
Recruiting
Phase 4
Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster
Herpes Zoster
Peking University Third Hospital140 enrolled4 locationsNCT07099157
Recruiting
Phase 4
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment
Congenital Adrenal Hyperplasia
Federico II University150 enrolled1 locationNCT03760835
Recruiting
Phase 4
High-Voltage Long-Duration Pulsed Radiofrequency Combined With Liposomal Bupivacaine Subcutaneous Block for Herpes Zoster-Associated Neuralgia
Herpes Zoster PainNeuralgia, Postherpetic
Shirong Tan46 enrolled1 locationNCT06959147
Recruiting
Phase 4
Investigating the Effect of Topical Imiquimod on Sebaceous Hyperplasia
Sebaceous Hyperplasia
University of Michigan40 enrolled1 locationNCT06840470
Recruiting
Phase 4
Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism
Primary Hyperparathyroidism
University of Aarhus140 enrolled1 locationNCT06859580
Recruiting
Phase 4
Randomized, Placebo-controlled, Double-blind Study of 2LHERP® in Orofacial Herpes Infections.
Herpes Simplex
Labo'Life140 enrolled6 locationsNCT04065971
Recruiting
Phase 4
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
Primary HyperparathyroidismHypercalcemia
Joseph Sferra37 enrolled1 locationNCT03935984
Recruiting
Phase 4
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Dilated CardiomyopathyKaposi's Sarcoma-Associated Herpesvirus Infection
Tongji Hospital276 enrolled1 locationNCT06236022
Recruiting
Phase 4
Prostate Medication, Metabolism and Gut Microbiota
Prostate CancerProstatic Hyperplasia
Turku University Hospital100 enrolled2 locationsNCT06001619
Recruiting
Phase 4
The Efficacy and Safety of Silodosin Singly or Combined With Ningmitai Capsules in the Treatment of Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
Xintian Pharmaceutical312 enrolled8 locationsNCT05551221
Completed
Phase 3Phase 4
A double-blind, randomised, placebo-controlled study to evaluate the effect of an orally-dosed herbal extract, Testofen, for the treatment of Benign Prostatic Hyperplasia (BPH) symptoms in otherwise healthy males.
Treatment of Benign Prostatic Hyperplasia (BPH)
Amanda Rao100 enrolled1 locationACTRN12615001242516
Not Yet Recruiting
Phase 4
The acute effects of Yohimbine on fear conditioning and the neural processing of emotional images, and on delayed extinction learning and memory for the images.
Healthy subjects, investigating the mechanisms underpinning Post Traumatic Stress Disorder
University of New South Wales120 enrolled1 locationACTRN12611000820909
Completed
Phase 4
Parathyroid gland size and responsiveness to cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism
Hemodialysis patients with secondary hyperparathyroidism
Kobe University School of Medicine75 enrolled1 locationACTRN12610000695000
Completed
Phase 4
“Effect of acid suppression on the effectiveness of phosphate binders in haemodialysis patients”
Hyperphosphataemia
King Saud University70 enrolled1 locationACTRN12610000437066
Completed
Phase 4
Calcium supplementation and its effect on bone loss in renal transplant recipients.
Bone loss in renal transplant recipients.Hyperparathyroidism in renal transplant recipients.
Dr Patrick T Coates35 enrolled1 locationACTRN12609000250235